Utilization of the ACQUITY PREMIER System and columns for improved oligonucleotide bioanalytical chromatographic performance

In this application note, Waters highlights the increased chromatographic performance for oligodeoxythymidines (ODTs) and the oligonucleotide antisense therapy, GEM91, using the ACQUITY PREMIER chromatographic system.